Indivior PLC is a global healthcare company focused primarily on the treatment of addiction and serious mental health conditions

It specializes in developing and commercializing innovative pharmaceutical products designed to support individuals struggling with substance use disorders, particularly opioid addiction. The company's portfolio includes medications that facilitate recovery by reducing cravings and withdrawal symptoms, thereby helping patients manage their addiction effectively. Indivior is committed to advancing research and development in this field, aiming to improve patient outcomes and support the global effort to combat addiction through comprehensive treatment solutions.